Published in Br J Pharmacol on July 01, 1980
Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis. Proc Natl Acad Sci U S A (1989) 1.26
Specific binding of leukotriene B4 to a receptor on human polymorphonuclear leukocytes. J Exp Med (1983) 1.17
Leukotriene B4-like material in scale of psoriatic skin lesions. Br J Pharmacol (1984) 1.05
Neutrophil stimulation by recombinant cytokines and a factor produced by IL-1-treated human synovial cell cultures. Immunology (1988) 0.96
Polymorphonuclear leukocyte histamine receptors: occurrence in cell surface clusters and their redistribution during locomotion. Proc Natl Acad Sci U S A (1986) 0.87
Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis. Br J Clin Pharmacol (1986) 0.86
Inhibition of ionophore-stimulated leukotriene B4 production in human leucocytes by monohydroxy fatty acids. Br J Pharmacol (1985) 0.84
The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin. Br J Clin Pharmacol (1984) 0.84
Phorbol myristate acetate enhances human polymorphonuclear neutrophil release of granular enzymes but inhibits chemokinesis. Br J Pharmacol (1985) 0.81
Aggregation of rat neutrophils by nucleotide triphosphates. Br J Pharmacol (1982) 0.80
Divergent effects of co-carcinogenic phorbol esters and a synthetic diacylglycerol on human neutrophil chemokinesis and granular enzyme secretion. Br J Pharmacol (1987) 0.80
Psoriatic skin lesions contain a novel lipid neutrophil chemokinetic compound which is distinct from known chemoattractant eicosanoids. Br J Pharmacol (1988) 0.77
Leukotriene B4: biological activities and the cytoskeleton. Br J Pharmacol (1982) 0.77
The chemokinetic response of psoriatic and normal polymorphonuclear leukocytes to arachidonic acid lipoxygenase products. Arch Dermatol Res (1986) 0.76
Proceedings of the British Pharmacological Society. Bath, 9th-11th April 1986. Abstracts. Br J Pharmacol (1986) 0.75
Proceedings of the British Pharmacological Society. Oxford, 9th-11th September 1987. Abstracts. Br J Pharmacol (1987) 0.75
Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med (1973) 14.88
In vitro cell migration as a model for delayed hypersensitivity. Proc Soc Exp Biol Med (1962) 11.91
The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils. J Exp Med (1976) 7.57
Macrophage migration from an agarose droplet: development of a micromethod for assay of delayed hypersensitivity. J Immunol (1973) 2.08
Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J Clin Invest (1974) 1.81
Selective neutrophil desensitization to chemotactic factors. J Cell Biol (1979) 1.77
In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils. J Immunol (1976) 1.76
Some effects of non-steroidal anti-inflammatory drugs on leucocyte migration. Agents Actions (1976) 1.62
Effect of some drugs on the chemotaxis of rabbit neutrophils in vitro. Experientia (1973) 1.53
The in vitro effects of histamine and metiamide on neutrophil motility and their relationship to intracellular cyclic nucleotide levels. J Immunol (1977) 1.49
Micropore filter assay of human granulocyte locomotion: problems and solutions. Clin Immunol Immunopathol (1978) 1.36
Neutrophil chemotaxis in rheumatoid arthritis. Effect of D-penicillamine, gold salts, and levamisole. Ann Rheum Dis (1978) 1.24
Effects of levamisole on normal and abnormal leukocyte locomotion. J Clin Invest (1977) 1.23
Directed migration of circulating polymorphonuclear leucocytes in patients with rheumatoid arthritis: a defect in the plasma. Ann Rheum Dis (1979) 1.16
Influence of surface proteins and separation techniques on neutrophil unstimulated and stimulated locomotion in vitro. J Reticuloendothel Soc (1978) 1.05
The effect of D-penicillamine on polymorphonuclear leukocyte function. J Clin Invest (1976) 1.05
The effects of D-pencillamine and levamisole on leucocyte chemotaxis in the rat. Br J Pharmacol (1978) 1.01
Action of nonsteroidal, anti-inflammatory drugs on human and rat peripheral leucocyte migration in vitro. Ann Rheum Dis (1977) 0.97
Inhibition of in vitro neutrophil chemotaxis and spontaneous motility by anti-inflammatory agents. Proc Soc Exp Biol Med (1976) 0.95
Role of ions and extracellular protein in leukocyte motility and membrane ruffling. Am J Pathol (1978) 0.94
Pharmacology of a new analgesic, antipyretic, and anti-inflammatory agent, 4-allyloxy-3-chlorophenylacetic acid. Arzneimittelforschung (1970) 0.91
Brief communication: technical modifications of the human agarose microdroplet leukocyte migration inhibition assay. J Immunol Methods (1978) 0.82
In vitro effects of non-steroidal anti-inflammatory drugs on human polymorphonuclear cells and lymphocyte migration. Br J Pharmacol (1978) 0.80
The effect of bovine serum albumin on the in vitro inhibition of chemotaxis by anti-inflammatory agents. Agents Actions (1977) 0.80
A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature (1990) 10.97
Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature (1980) 9.25
Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol (1999) 7.69
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A (2001) 6.68
A comparison of the Celera and Ensembl predicted gene sets reveals little overlap in novel genes. Cell (2001) 4.36
Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity. Proc Natl Acad Sci U S A (1983) 4.32
Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature (1996) 4.12
Regulation of bacterial cell division: temperature-sensitive mutants of Escherichia coli that are defective in septum formation. J Bacteriol (1975) 3.94
Full and partial posttraumatic stress disorder: findings from a community survey. Am J Psychiatry (1997) 3.55
The Memorial Delirium Assessment Scale. J Pain Symptom Manage (1997) 3.55
Nucleotide sequence analysis of the transforming region and large terminal redundancies of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1980) 2.93
Obstruction due to retained carbon dioxide absorber canister wrapping. Anesth Analg (1996) 2.65
Conditional mutations involving septum formation in Escherichia coli. J Bacteriol (1967) 2.64
An association between actin and the major histocompatibility antigen H-2. Nature (1978) 2.63
Programmed ribosomal frameshifting generates the Escherichia coli DNA polymerase III gamma subunit from within the tau subunit reading frame. Nucleic Acids Res (1990) 2.61
High-dose beclomethasone inhaler in the treatment of asthma. Lancet (1983) 2.58
Evidence for a relationship between deoxyribonucleic acid metabolism and septum formation in Escherichia coli. J Bacteriol (1968) 2.54
Complete nucleotide sequence and organization of the Moloney murine sarcoma virus genome. Science (1981) 2.51
Studies on nucleic acid reassociation kinetics: reactivity of single-stranded tails in DNA-DNA renaturation. Proc Natl Acad Sci U S A (1975) 2.50
Bacterial cell division regulation: lysogenization of conditional cell division lon - mutants of Escherichia coli by bacteriophage. J Bacteriol (1973) 2.46
Bacterial cell division regulation: characterization of the dnaH locus of Escherichia coli. J Bacteriol (1974) 2.41
Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax (1983) 2.35
Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett (1998) 2.26
A safety screening questionnaire for transcranial magnetic stimulation. Clin Neurophysiol (2001) 2.20
Leukotriene B: a potential mediator of inflammation. J Pharm Pharmacol (1980) 2.13
The E. coli dnaY gene encodes an arginine transfer RNA. Cell (1986) 2.11
Inoculum-dependent division lag of Bacillus cultures and its relation to an endogenous factor(s) ("schizokinen"). J Bacteriol (1966) 2.07
Inhibition of lipid synthesis in Escherichia coli cells by the antibiotic cerulenin. Antimicrob Agents Chemother (1973) 2.06
Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population-based cohort. Aliment Pharmacol Ther (2013) 2.05
Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology (2000) 2.04
Regulation of bacterial cell division: genetic and phenotypic analysis of temperature-sensitive, multinucleate, filament-forming mutants of Escherichia. J Bacteriol (1974) 1.92
Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet (2008) 1.84
Isolation and characterization of dnaX and dnaY temperature-sensitive mutants of Escherichia coli. Genetics (1979) 1.83
The Yersinia enterocolitica motility master regulatory operon, flhDC, is required for flagellin production, swimming motility, and swarming motility. J Bacteriol (1999) 1.81
Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax (1981) 1.80
Coeliac disease and diffuse interstitial lung disease. Lancet (1971) 1.80
Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci U S A (1999) 1.73
Models for tertiary structures. Myoglobin and lysozyme. J Chem Educ (1970) 1.70
Nucleotide sequence of the Escherichia coli replication gene dnaZX. Nucleic Acids Res (1986) 1.69
Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis. Lancet (1987) 1.66
Length heteroplasmy of sturgeon mitochondrial DNA: an illegitimate elongation model. Genetics (1990) 1.65
Childhood abuse, adult health, and health care utilization: results from a representative community sample. Am J Epidemiol (2007) 1.63
Mycobacterial isolations in young adults with cystic fibrosis. Thorax (1984) 1.60
Leukotriene B4: a mediator of vascular permeability. Br J Pharmacol (1981) 1.57
Gender differences in susceptibility to posttraumatic stress disorder. Behav Res Ther (2000) 1.57
Frameshift suppression at tandem AGA and AGG codons by cloned tRNA genes: assigning a codon to argU tRNA and T4 tRNA(Arg). Nucleic Acids Res (1990) 1.56
Social phobia in adults with stuttering. Am J Psychiatry (1996) 1.55
Setting diagnostic thresholds for social phobia: considerations from a community survey of social anxiety. Am J Psychiatry (1994) 1.54
Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes (1995) 1.54
Work organization and ergonomics. Appl Ergon (2000) 1.53
Growth of phages lambda, phiX174, and Ml3 requires the dnaZ (previously dnaH) gene product of Escherichia coli. Biochem Biophys Res Commun (1974) 1.53
Cell division of the Escherichia coli lon- mutant. Mol Gen Genet (1970) 1.51
Influence of moderate daily wine consumption on body weight regulation and metabolism in healthy free-living males. J Am Coll Nutr (1997) 1.51
Pelvic lipomatosis: 35-year experience. J Urol (1988) 1.50
Surgical delay in the management of dog bite injuries in children, does it increase the risk of infection? J Plast Reconstr Aesthet Surg (2006) 1.50
Cloning of the Escherichia coli dnaZX region and identification of its products. Mol Gen Genet (1983) 1.49
Hospitalised patients' views on doctors and white coats. Med J Aust (2001) 1.48
Leukotriene B4: an inflammatory mediator in vivo. Prostaglandins (1981) 1.48
Anti-inflammatory drugs, prostaglandins and leucocyte migration. Agents Actions (1976) 1.45
A method for extracting ferruginous bodies from sputum and pulmonary tissue. Am J Clin Pathol (1972) 1.44
Physicochemical evolution and molecular adaptation of the cetacean and artiodactyl cytochrome b proteins. Mol Biol Evol (2004) 1.44
The relationship between wages and income and the timing and spacing of births: evidence from Swedish longitudinal data. Econometrica (1990) 1.43
The effects of salicylate on the activity of rat liver tryptophan pyrrolase in vitro and in vivo. Biochem J (1971) 1.43
Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension (1993) 1.43
Physical trauma and breast cancer. Lancet (1994) 1.42
Characterization of the cryptic lambdoid prophage DLP12 of Escherichia coli and overlap of the DLP12 integrase gene with the tRNA gene argU. J Bacteriol (1989) 1.42
Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest (1995) 1.40
Changes in liver tryptophan and tryptophan pyrrolase activity after administration of salicylate and tryptophan to the rat. Biochem Pharmacol (1972) 1.40
Three incidents of industrial mass psychogenic illness: a preliminary report. J Occup Med (1978) 1.40
The myth of the Brooks method of embolization: a brief history of the endovascular treatment of carotid-cavernous sinus fistula. J Neurointerv Surg (2009) 1.39
Risk factors for immersion pulmonary edema: hyperoxia does not attenuate pulmonary hypertension associated with cold water-immersed prone exercise at 4.7 ATA. J Appl Physiol (1985) (2010) 1.39
Dealing with skewed data: an example using asthma-related costs of medicaid clients. Clin Ther (2001) 1.38
Social phobia symptoms, subtypes, and severity: findings from a community survey. Arch Gen Psychiatry (2000) 1.35
Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis. Ann Rheum Dis (1983) 1.35
Exstrophy closure: a followup on 70 cases. J Urol (1966) 1.34
The Escherichia coli DNA polymerase III holoenzyme contains both products of the dnaX gene, tau and gamma, but only tau is essential. J Bacteriol (1993) 1.34
Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours. Eur J Cancer Clin Oncol (1987) 1.33
Isomers of leukotriene B4 possess different biological potencies. Prostaglandins (1981) 1.33
Chronic cocaine treatment decreases levels of the G protein subunits Gi alpha and Go alpha in discrete regions of rat brain. J Neurochem (1990) 1.32
Relation of the Escherichia coli dnaX gene to its two products--the tau and gamma subunits of DNA polymerase III holoenzyme. Nucleic Acids Res (1987) 1.25
High-titre anti-CMV plasma in treatment of neonatal cytomegalovirus infection. Lancet (1984) 1.24
Public-speaking fears in a community sample. Prevalence, impact on functioning, and diagnostic classification. Arch Gen Psychiatry (1996) 1.24
Clinical review of pulmonary disease caused by Mycobacterium xenopi. Thorax (1983) 1.23
Sequence of tRNA(Thr) and tRNA(Pro) from white sturgeon (Acipenser transmontanus) mitochondria. Nucleic Acids Res (1988) 1.23
Effects of a human plasma fraction on leucocyte migration into inflammatory exudates. J Pharm Pharmacol (1975) 1.23
The relationship between reasons for drinking alcohol and alcohol consumption: an interactional approach. Addict Behav (1994) 1.23
Spectral analysis of Doppler signals and computation of the normalised first moment in real time using a digital signal processor. Med Biol Eng Comput (1988) 1.22
Expression of the Escherichia coli cell division gene sep cloned in a lambda Charon phage. Science (1979) 1.22
Repetitive and non-repetitive sequence in sea urchin heterogeneous nuclear RNA. J Mol Biol (1974) 1.21
Inhibitory effect of salicylate on the incorporation of L-(U-14C)leucine into the protein of rat tissue preparations in vitro. Biochem J (1966) 1.21
Work organization, job stress, and work-related musculoskeletal disorders. Hum Factors (1999) 1.21
Chronic blockade of angiotensin II formation during sodium deprivation. Am J Physiol (1979) 1.21
Applying quality improvement principles to achieve healthy work organizations. Jt Comm J Qual Improv (2001) 1.20
Leukotriene B4, an inflammatory mediator in gout. Lancet (1982) 1.20
FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett (1999) 1.19
Fatal pulmonary infection with Mycobacterium fortuitum in cystic fibrosis. Br J Dis Chest (1984) 1.18
Heparin-induced skin necrosis and low molecular weight heparins. Ann R Coll Surg Engl (1999) 1.18